Document is current
Any future updates will be listed below
-
Authors
Zhao, Xuelian
Wang, Honghao
Hong, Yuting
Du, Qiaoyun
Zhang, Yuanyuan
Hu, Shangying
Yuan, Meiwen
Yang, Hongying
Wang, Yan
Cui, Xiaoli
Zhang, Yongzhen
Zhang, Shaokai
Wang, Wenjun
Han, Guang
Li, Li
Ding, Chao
Zhao, Fanghui
-
Funding
Funding for this research was provided by:
Merck
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 8 April 2026
First Online: 24 April 2026
Declarations
:
: The study protocol was approved by the Ethics Committee of the National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (Approval No.: NCC 20/041 2237). All procedures were performed in accordance with the relevant guidelines. Written informed consent was obtained from all participating patients during routine follow-ups. For deceased or unreachable patients, the requirement for informed consent was waived by the ethics committee.
: Not applicable.
: The authors declare no competing interests.
